The risk of osteoporosis in patients with ankylosing spondylitis-A large retrospective matched cohort study.

[1]  A. Cohen,et al.  TNF inhibitors have a protective role in the risk of dementia in patients with ankylosing spondylitis: Results from a nationwide study. , 2022, Pharmacological Research.

[2]  A. Cohen,et al.  Ankylosing Spondylitis and the Risk of Hip Fractures: a Matched Cohort Study , 2022, Journal of General Internal Medicine.

[3]  Y. Goh,et al.  A comprehensive overview on osteoporosis and its risk factors , 2018, Therapeutics and clinical risk management.

[4]  Y. Shoenfeld,et al.  The link between schizophrenia and hypothyroidism: a population-based study , 2018, Immunologic research.

[5]  S. Tiosano,et al.  The link between COPD and ankylosing spondylitis: A population based study. , 2018, European journal of internal medicine.

[6]  Li Xue,et al.  TNF-α contributes to postmenopausal osteoporosis by synergistically promoting RANKL-induced osteoclast formation. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[7]  H. Doll,et al.  Delay to diagnosis in axial spondyloarthritis: are we improving in the UK? , 2015, Rheumatology.

[8]  C. Roux,et al.  Inflammation, bone loss and fracture risk in spondyloarthritis , 2015, RMD Open.

[9]  M. Dougados,et al.  Axial spondyloarthritis , 2015, Nature Reviews Disease Primers.

[10]  D. Heijde,et al.  Nonradiographic Axial Spondyloarthritis New Definition of an Old Disease ? , 2013 .

[11]  M. Dougados,et al.  Bone oedema on MRI is highly associated with low bone mineral density in patients with early inflammatory back pain: results from the DESIR cohort , 2012, Annals of the rheumatic diseases.

[12]  D. Mellström,et al.  Osteoporosis in ankylosing spondylitis - prevalence, risk factors and methods of assessment , 2012, Arthritis Research & Therapy.

[13]  J. Gu,et al.  Pathogenesis of ankylosing spondylitis , 2010, Nature Reviews Rheumatology.

[14]  A. Maghraoui,et al.  Prevalence and risk factors of osteoporosis and vertebral fractures in patients with ankylosing spondylitis. , 2009, Bone.

[15]  P. Pietschmann,et al.  The HLA-B27 Transgenic Rat, a Model of Spondyloarthritis, Has Decreased Bone Mineral Density and Increased RANKL to Osteoprotegerin mRNA Ratio , 2008, Journal of Rheumatology.

[16]  M. Dougados,et al.  Prospective assessment of body weight, body composition, and bone density changes in patients with spondyloarthropathy receiving anti-tumor necrosis factor-alpha treatment. , 2008, The Journal of rheumatology.

[17]  L. Hofbauer,et al.  Evaluation of bone mineral density, hormones, biochemical markers of bone metabolism, and osteoprotegerin serum levels in patients with ankylosing spondylitis. , 2004, The Journal of rheumatology.

[18]  M. Dougados,et al.  What is the most appropriate radiologic scoring method for ankylosing spondylitis? A comparison of the available methods based on the Outcome Measures in Rheumatology Clinical Trials filter. , 2004, Arthritis and rheumatism.

[19]  Jürgen Braun,et al.  Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis , 2003, Rheumatology International.

[20]  M. Dougados,et al.  Osteoporosis, body composition, and bone turnover in ankylosing spondylitis. , 1999, The Journal of rheumatology.

[21]  C. A. Hanson,et al.  Vertebral osteoporosis in ankylosing spondylitis. , 1971, Clinical orthopaedics and related research.